India has achieved a significant milestone today (May 26). It has crossed the 20-crore mark
Bengaluru: In its fight against the second virus of the coronavirus pandemic, India continues to inoculate its citizens.
And as it continues the vaccination drive, it has achieved a significant milestone today (May 26). It has crossed the 20-crore mark (with 20,06,62,456 doses including 15,71,49,593 first dose and 4,35,12,863 second dose of COVID-19 vaccines), as per statement issued by the ministry of health and family welfare.
It might be recalled that India launched the vaccination drive on January 16 by the Prime Minister.
It is also the worlds’ largest vaccination drive.
It is also pertinent to note that India is the second country after the USA to achieve this coverage in just 130 days. The USA took 124 days to reach the 20-crore mark.
Additionally, as per the data available on Our World In Data and multiple news articles, other leading countries in COVID-19 vaccination drive include the UK which has reached 5.1 crore mark in 168 days, Brazil that reached 5.9 crore mark in 128 days, and Germany which reached 4.5 crore mark in 149 days.
As of date, India is using three vaccines against COVID-19 in its immunization drive; these include two made in India vaccines - Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin. The Russian Sputnik V is the third vaccine to get approval from the Drug Controller General of India (DCGI) for Emergency Use Authorisation and is being used in few private hospitals which are expected to be increased over the coming days.
In Phase I of the vaccination drive, started 130 days ago on 16th January, the National Expert Group on Vaccine Administration for Covid-19 (NEGVAC) prioritized Health Care Workers, and Frontline Workers (both government & private sector). Phase II of the vaccination drive started from 1st March 202, focused on protecting the most vulnerable age groups. These prioritized age-groups included persons above 60 years of age and persons above 45 years with associated specified co-morbidities. This was further relaxed to all people above 45 years of age on 1st April 2021. In Phase III, ‘Liberalised Pricing and Accelerated National COVID-19 Vaccination Strategy’ was adopted on 1st May 2021. Under this strategy, everyone above 18 years of age are eligible for COVID-19 vaccination.
Read Exclusive COVID-19 Coronavirus News updates, at MyNation.